Metildigoxin is a synthetic cardiac glycoside used primarily in the clinical management of congestive heart failure and cardiac arrhythmias by inhibiting the Na+/K+-ATPase pump. Laboratories utilize high-quality… Read more
Metildigoxin is a synthetic cardiac glycoside used primarily in the clinical management of congestive heart failure and cardiac arrhythmias by inhibiting the Na+/K+-ATPase pump. Laboratories utilize high-quality reference standards of Metildigoxin, along with its specific pharmacopeial and non-pharmacopeial impurities, to ensure rigorous analytical testing and quality control of the active pharmaceutical ingredient. These materials are essential for accurate impurity profiling and method validation throughout the drug development and manufacturing lifecycle. Furthermore, stable isotope labelled compounds in this category serve as critical internal standards for mass spectrometry-based assays, allowing for precise quantification and structural identification. By providing reliable materials for these complex analytical workflows, this collection supports the maintenance of strict regulatory compliance and the consistent safety profile of the therapeutic agent.